SLC25A6 and cancer: The reduction in cyclin D1 after siANT2 treatment was also observed in other cancer cell lines, such as MDA-MB-231, SK-MEL-28, A549 and RKO cells (Figure 3d), suggesting that ANT2 functions as an oncoprotein.